Carisbamate vs topiramate vs levetiracetam adjunctive therapy study in partial-onset seizures

Phase 3, randomised, double-blind trial in Focal Onset Epilepsy and focal-onset epileptic seizures comparing Carisbamate adjunctive therapy, Topiramate adjunctive therapy and Levetiracetam adjunctive therapy (3 arms). Primary endpoints: Primary efficacy endpoint and Primary objective endpoint. Started Aug 2007; status: terminated.